tiprankstipranks
Trending News
More News >

New Portfolio - New Portfolio

Shawn Chowdhury

New Portfolio
Individual Investor
Ranked #327,661 out of 795,368 TipRanks' Investors
Success Rate
46%
548 out of 1194
profitable transactions
Average Return
4.66%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▼ 9.44%
6-Month Return▼ 11.45%
12-Month Return▲ 1.38%
YTD Return▼ 13.47%
Total Return▲ 20.79%

Best Trade

Opened at
Closed at
Gain▲ 986.01%

Bio

Aggressive Growth with 3 year time horizon starting October 2020

Performance

25.98%0-25.98%
▲ 2.92%
▲ 2.10%
▲ 6.92%
Sep 2024
▲ 10.00%
▼ 0.89%
▲ 0.22%
Oct 2024
▲ 25.98%
▲ 5.96%
▲ 8.24%
Nov 2024
▲ 5.34%
▼ 2.41%
▼ 5.14%
Dec 2024
▲ 5.99%
▲ 2.69%
▲ 3.74%
Jan 2025
▼ 12.86%
▼ 1.27%
▼ 3.01%
Feb 2025
▼ 1.80%
▼ 5.57%
▼ 6.05%
Mar 2025
▼ 13.55%
▼ 6.22%
▼ 8.46%
Apr 2025
TipRanks AverageS&P 500Investor Portfolio
▲ 2.92%▲ 2.10%▲ 6.92%
▲ 10.00%▼ 0.89%▲ 0.22%
▲ 25.98%▲ 5.96%▲ 8.24%
▲ 5.34%▼ 2.41%▼ 5.14%
▲ 5.99%▲ 2.69%▲ 3.74%
▼ 12.86%▼ 1.27%▼ 3.01%
▼ 1.80%▼ 5.57%▼ 6.05%
▼ 13.55%▼ 6.22%▼ 8.46%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Pactiv Evergreen
▲ 54.31%
3
Close
Mar 31, 2025
Fresh Tracks Therapeutics
▼ 98.49%
2
Close
Feb 28, 2025
Staffing 360 Solutions
▼ 99.77%
3
Close
Feb 12, 2025
Atlantic International
0%
▲ 23.96%
1
Open
Feb 12, 2025
Fission Uranium
▲ 27.86%
3
Close
Dec 24, 2024
Paladin Energy Ltd
0%
▼ 41.48%
1
Open
Dec 24, 2024
Bellerophon
▼ 99.85%
2
Close
Dec 18, 2024
Iteris
▲ 16.16%
3
Close
Oct 31, 2024
Petiq
▲ 0.04%
3
Close
Oct 24, 2024
Phasebio Pharmaceuticals
▼ 99.48%
3
Close
Oct 01, 2024
G1 Therapeutics
▼ 51.28%
5
Close
Sep 17, 2024
Morphosys Ag
▼ 34.34%
3
Close
Aug 02, 2024
Cerevel Therapeutics Holdings
▲ 213.72%
3
Close
Jul 31, 2024
Argonaut Gold
▼ 80.91%
2
Close
Jul 16, 2024
Alamos Gold
0%
▲ 26.00%
3
Open
Jul 16, 2024
Invitae
▼ 99.98%
3
Close
Jul 08, 2024
Alpine Immune Sciences
▲ 390.71%
2
Close
May 17, 2024
Electrameccanica Vehicles
▼ 97.33%
2
Close
Mar 27, 2024
Xos
0%
▼ 67.12%
1
Open
Mar 27, 2024
CymaBay Therapeutics
▲ 431.59%
2
Close
Mar 25, 2024